Literature DB >> 10068162

Spatial and temporal summation of sensory and affective dimensions of deep somatic pain.

C S Stohler1, C J Kowalski.   

Abstract

There is considerable evidence in support of differential information processing of the sensory-discriminative and motivational-affective meanings of pain. The purpose of this work was to examine whether temporal (acute, tonic, persistent) and spatial (local, regional, widespread) aspects of deep somatic pain influence the sensory and affective dimensions of pain. Acute pain consisted of a short bout of pain, lasting about 100 s. Tonic pain was the experience of experimentally maintained pain for 18 min. Both acute and tonic pain were induced by infusion of an algesic or control substance into muscle with the subject blinded with respect to the type of infusion and randomization of the application sequence. Comparing the response of experimental subjects to a group of matched cases with persistent masticatory myalgia alone or in combination with widespread musculoskeletal pain, we examine whether the experimental state is different from the matched clinical condition, and whether there is a difference between the condition being restricted to the face or not. The McGill pain questionnaire was used to assess the sensory and affective correlates of pain. The normalized sensory score for acute/unilateral face pain was different from that established for tonic/unilateral face pain (P = 0.055, borderline s.), and so was the normalized affective score (P = 0.009, s.). When comparing tonic/unilateral versus tonic/bilateral face pain, the affective scores increased with increased pain involvement (P = 0.009, s.) while the sensory sores were unaffected by the additional pain induced in the contralateral masseter muscle (P = 0.357, n.s). Notably, sensory and affective scores for tonic/bilateral and persistent/bilateral face pain were not statistically different (sensory: P = 0.169, n.s.; affective: P = 0.643, n.s). On the other hand, when contrasting persistent/bilateral face pain with persistent/ widespread musculoskeletal pain, both scores were significantly different (sensory: P < 0.001, s.; affective: P = 0.041, s.). Time in and spread of pain influenced the perceptual correlates of pain to a significant degree. The major increase in the sensory dimension occurred from 'no pain' to 'acute pain'. Affective scores showed the most significant increases from acute to tonic pain, particularly with greater spatial involvement. The significant increases in sensory scores observed when contrasting persistent facial pain alone and in combination with widespread musculoskeletal pain was attributed to the broader body experience. Because the perceptual correlates of tonic and matched persistent (chronic) pain states were similar, we concluded that it does not require months for the development of the sensory and affective meaning of persistent pain as assumed.

Entities:  

Mesh:

Year:  1999        PMID: 10068162     DOI: 10.1016/s0304-3959(98)00171-7

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  27 in total

1.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.

Authors:  Yolanda R Smith; Christian S Stohler; Thomas E Nichols; Joshua A Bueller; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

3.  Neurobiology of placebo effects: expectations or learning?

Authors:  Marta Peciña; Christian S Stohler; Jon-Kar Zubieta
Journal:  Soc Cogn Affect Neurosci       Date:  2013-07-24       Impact factor: 3.436

4.  Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans.

Authors:  Marta Peciña; Mercedes Martínez-Jauand; Tiffany Love; Joseph Heffernan; Pedro Montoya; Colin Hodgkinson; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 5.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

6.  Characterization of Source-Localized EEG Activity During Sustained Deep-Tissue Pain.

Authors:  Juan Manuel Völker; Federico Gabriel Arguissain; José Biurrun Manresa; Ole Kæseler Andersen
Journal:  Brain Topogr       Date:  2021-01-05       Impact factor: 3.020

7.  Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.

Authors:  Marta Peciña; Tiffany Love; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  Neuropsychopharmacology       Date:  2014-10-13       Impact factor: 7.853

Review 8.  The missing p in psychiatric training: why it is important to teach pain to psychiatrists.

Authors:  Igor Elman; Jon-Kar Zubieta; David Borsook
Journal:  Arch Gen Psychiatry       Date:  2011-01

9.  Oxytocin gene polymorphisms influence human dopaminergic function in a sex-dependent manner.

Authors:  Tiffany M Love; Mary-Anne Enoch; Colin A Hodgkinson; Marta Peciña; Brian Mickey; Robert A Koeppe; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  Biol Psychiatry       Date:  2012-03-13       Impact factor: 13.382

10.  mu-opioid receptor-mediated antinociceptive responses differ in men and women.

Authors:  Jon-Kar Zubieta; Yolanda R Smith; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Douglas M Jewett; Charles R Meyer; Robert A Koeppe; Christian S Stohler
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.